News. Time to buy!
Sentiment: Strong Buy
I hope the dorks from the FDA don't require a Phase III on such a safe and obvious approval candidate.
They might not ask for a P3 but I would think they will demand a 2B with several hundred more people. JMHO though.
it really does seem like a perfect candidate for accelerated approval, orphan drug status.
The results could not have been more striking.